MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%

Sector Heatmap

Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%

SVA — Sinovac Biotech, Ltd

Nasdaq

Sinovac Biotech, Ltd

CompareBack to Screener
$6.47
+0.00(+0.00%)
O
6.47
H
6.47
L
6.47
V
0
⏱️ End-of-day dataAs of Jul 16, 2026

Chart

About SVA

Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

IndustryCommon Stock
SectorNot available
IPO DateSep 26, 2003
Employees2,602
Stock ExchangeNasdaq
Ticker SymbolSVA

Key Financial Statistics

Market CapN/A
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$6.47 - $6.47
52-Week Avg Volume0
Total Recorded Bars5,727 days